+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
From
Chronic Idiopathic Urticaria- Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Idiopathic Urticaria- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Rosacea - Pipeline Insight, 2025 - Product Thumbnail Image

Rosacea - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Merkel Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Merkel Cell Carcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Keratinocyte Growth Factor Market - Global Forecast 2025-2032 - Product Thumbnail Image

Keratinocyte Growth Factor Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 195 Pages
  • Global
From
From
From
From
Hereditary Angioedema Therapeutics Market Report 2026 - Product Thumbnail Image

Hereditary Angioedema Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Migraine Market Report 2026 - Product Thumbnail Image

Migraine Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
US Biosimilar industry outlook to 2028 - Product Thumbnail Image

US Biosimilar industry outlook to 2028

  • Report
  • October 2023
  • 85 Pages
  • United States
From
From
Migraine Treatment Market Report 2026 - Product Thumbnail Image

Migraine Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Loading Indicator